Real-time enrollment status for this glioblastoma, idh-wildtype clinical trial
Current Status
Recruiting
Checked: August 30, 2026 at 2:25 AM UTC
| NCT Number | NCT06319027 |
| Recruiting Status | Recruiting |
| Condition | Glioblastoma, IDH-Wildtype |
| Phase | PHASE2 |
| Target Enrollment | 100 participants |
| Active Locations | 18 sites in the US |
| Sponsor | ECOG-ACRIN Cancer Research Group |
| Last Updated on CT.gov | August 18, 2026 (1 week ago) |
As of August 30, 2026: Clinical trial NCT06319027 is currently recruiting participants. This phase2 study for glioblastoma, idh-wildtype is actively seeking new participants at 18 locations across the United States. The study is sponsored by ECOG-ACRIN Cancer Research Group. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06319027 is actively recruiting participants as of August 30, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 18 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06319027 was last updated 1 week ago (August 18, 2026). HelloStudys verifies this status automatically.